Keyphrases
R-CHOP
100%
High Risk
100%
BCL6
100%
B-cell Lymphoma 2 (Bcl-2)
100%
R-CHOP Chemotherapy
100%
Young Patients
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Prognostic Biomarker
100%
Bcl-2 Family Proteins
33%
Progression-free Survival
33%
MYC Protein
33%
Patient Cohort
33%
Population-based Cohort
16%
Tumor Samples
16%
Germinal Center B Cells
16%
Prognostic Marker
16%
Prognostic Value
16%
Lymphoma
16%
Lymphoma Therapy
16%
Etoposide
16%
World Health Organization Classification
16%
Predictive Value
16%
Quantitative Immunohistochemistry
16%
Double Hit
16%
Immunophenotyping
16%
Fluorescence in Situ Hybridization
16%
Improved Survival
16%
Prognostic Impact
16%
Predictive Effect
16%
Medicine and Dentistry
Biological Marker
100%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
100%
Diffuse Large B-Cell Lymphoma
100%
Progression Free Survival
18%
Neoplasm
18%
Neuroscience
CHOP
100%
B Cell
100%
